G.J. Hanna, J. Kaczmar, D. Zandberg, D.J. Wong, E. Yilmaz, E. Sherman, A. Hernando-Calvo, A. Sacco, D. Raben, L. Odogwu, D. Bohr, R. Salazar, R. Reiners, C.S. Chung
{"title":"双功能表皮生长因子受体/表皮生长因子β抑制剂BCA101联合Pembrolizumab治疗复发性、转移性头颈部鳞状细胞癌患者的1/1b期研究的最新剂量扩增结果","authors":"G.J. Hanna, J. Kaczmar, D. Zandberg, D.J. Wong, E. Yilmaz, E. Sherman, A. Hernando-Calvo, A. Sacco, D. Raben, L. Odogwu, D. Bohr, R. Salazar, R. Reiners, C.S. Chung","doi":"10.1016/j.ijrobp.2024.01.194","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":14219,"journal":{"name":"International Journal of Radiation Oncology*Biology*Physics","volume":"9 7","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Updated Dose Expansion Results of a Phase 1/1b Study of the Bifunctional EGFR/TGFβ Inhibitor BCA101 with Pembrolizumab in Patients with Recurrent, Metastatic Head and Neck Squamous Cell Carcinoma\",\"authors\":\"G.J. Hanna, J. Kaczmar, D. Zandberg, D.J. Wong, E. Yilmaz, E. Sherman, A. Hernando-Calvo, A. Sacco, D. Raben, L. Odogwu, D. Bohr, R. Salazar, R. Reiners, C.S. Chung\",\"doi\":\"10.1016/j.ijrobp.2024.01.194\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":14219,\"journal\":{\"name\":\"International Journal of Radiation Oncology*Biology*Physics\",\"volume\":\"9 7\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Radiation Oncology*Biology*Physics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.ijrobp.2024.01.194\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Radiation Oncology*Biology*Physics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.ijrobp.2024.01.194","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Updated Dose Expansion Results of a Phase 1/1b Study of the Bifunctional EGFR/TGFβ Inhibitor BCA101 with Pembrolizumab in Patients with Recurrent, Metastatic Head and Neck Squamous Cell Carcinoma